Company Search:
Advanced Search
Sponsored Links
Generex Biotechnology Corporation Company Snapshot
Generex Biotechnology Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Generex Biotechnology with three other companies in this sector in the United States: Alpine Immune Sciences Inc (2018 sales of $705,000.00 of which 100% was Protein-based immunotherapies), Catalyst Pharmaceuticals Inc ($500,000.00 of which 100% was Prescription Drugs), and Stemline Therapeutics Inc ($500,000.00 of which 100% was Bio-Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Generex Biotechnology Corporation
  Stock Performance Chart for Generex Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 2.03
(Figures in U.S. Dollars)
1 Week -2.9%   13 Weeks -21.9%  
4 Weeks -28.3%   52 Weeks 509.0%  
Generex Biotechnology Corporation Key Data:
  Ticker: GNBT Country: United States
  Exchanges: FRA OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 703,244
(Year Ending Jan 2019).
Employees: 8
  Currency: U.S. Dollars Market Cap: 122,535,191
  Fiscal Yr Ends: July Shares Outstanding: 60,362,163
  Share Type: Common Closely Held Shares: 6,564,159
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.